AGL 37.84 Decreased By ▼ -0.16 (-0.42%)
AIRLINK 217.49 Increased By ▲ 3.58 (1.67%)
BOP 9.49 Increased By ▲ 0.07 (0.74%)
CNERGY 6.61 Increased By ▲ 0.32 (5.09%)
DCL 8.70 Decreased By ▼ -0.07 (-0.8%)
DFML 43.09 Increased By ▲ 0.88 (2.08%)
DGKC 95.10 Increased By ▲ 0.98 (1.04%)
FCCL 35.55 Increased By ▲ 0.36 (1.02%)
FFBL 88.94 No Change ▼ 0.00 (0%)
FFL 17.73 Increased By ▲ 1.34 (8.18%)
HUBC 127.66 Increased By ▲ 0.76 (0.6%)
HUMNL 13.85 Increased By ▲ 0.48 (3.59%)
KEL 5.36 Increased By ▲ 0.05 (0.94%)
KOSM 6.90 Decreased By ▼ -0.04 (-0.58%)
MLCF 43.63 Increased By ▲ 0.65 (1.51%)
NBP 59.40 Increased By ▲ 0.55 (0.93%)
OGDC 222.98 Increased By ▲ 3.56 (1.62%)
PAEL 39.61 Increased By ▲ 0.45 (1.15%)
PIBTL 8.25 Increased By ▲ 0.07 (0.86%)
PPL 195.50 Increased By ▲ 3.84 (2%)
PRL 38.90 Increased By ▲ 0.98 (2.58%)
PTC 27.68 Increased By ▲ 1.34 (5.09%)
SEARL 104.75 Increased By ▲ 0.75 (0.72%)
TELE 8.61 Increased By ▲ 0.22 (2.62%)
TOMCL 35.50 Increased By ▲ 0.75 (2.16%)
TPLP 13.19 Increased By ▲ 0.31 (2.41%)
TREET 25.40 Increased By ▲ 0.06 (0.24%)
TRG 72.17 Increased By ▲ 1.72 (2.44%)
UNITY 33.20 Decreased By ▼ -0.19 (-0.57%)
WTL 1.72 No Change ▼ 0.00 (0%)
BR100 11,993 Increased By 99.2 (0.83%)
BR30 37,338 Increased By 483.4 (1.31%)
KSE100 111,637 Increased By 1213.4 (1.1%)
KSE30 35,162 Increased By 384.3 (1.11%)

Persons addicted to heroin or prescription pain killers can get help kicking their habit by using an implanted device under the skin that delivers small doses of medication, researchers reported on October 12.
A study led by Walter Ling of the University of California-Los Angeles found that persons receiving the implants of buprenorphine had more success in ending their dependence on opioids, which include heroin and prescription pain medications, with fewer symptoms of withdrawal.
"Those who received buprenorphine implants also had fewer clinician-rated and patient-rated withdrawal symptoms, had lower patient ratings of craving and experienced a greater change... on the clinician global ratings of improvement than those who received placebo implants," the researchers wrote in the Journal of the American Medical Association.
Ling and his colleagues conducted a study of 163 adults diagnosed with opioid dependence at 18 locations in the United States between April 2007 and June 2008. Of the group, 108 received buprenorphine implants and 55 got placebo implants. The implants were placed below the skin in the inner side of the non-dominant arm.
The implants, which gradually released 80 milligrams of buprenorphine, were removed after six months, as were the placebos.
Patients with buprenorphine implants tested negative for illicit drugs an average of 40.4 percent of the time compared to 28.3 percent for the placebo group. Additionally, 65.7 percent of patients in the buprenorphine implant group remained in the study for the full 24-week study period compared to 30.9 percent of patients in the placebo group.
The medication has previously been tried in treating addiction by administering the drug under the tongue, but researchers found that patients failed to rigorously follow the dosing schedule.

Copyright Agence France-Presse, 2010

Comments

Comments are closed.